Skip to Content

Most Viewed

  • Feature Paper
  • Review
  • Open Access
77 Citations
63,952 Views
26 Pages

30 May 2022

Sickle cell disease and its variants constitute the most common inherited blood disorders affecting millions of individuals worldwide. Significant information regarding the nature of the genetic mutations and modifier genes that result in increased o...

(This article belongs to the Section Non Neoplastic Blood Disorders)
  • Perspective
  • Open Access
4 Citations
29,724 Views
23 Pages

29 March 2023

Myeloid leukemias are a broad group of hematological disorders, characterized by heterogeneous clinical and biological features. In recent years, unprecedented genetic discoveries and clinical–biological correlations have revolutionized the fie...

(This article belongs to the Section Leukemias)
  • Review
  • Open Access
9 Citations
26,945 Views
29 Pages

Review of Peripheral Blood Eosinophilia: Workup and Differential Diagnosis

  • Michael Dennis Weaver,
  • Bianca Glass,
  • Chance Aplanalp,
  • Gauri Patel and ,
  • Jeshrine Mazhil,
  • Isabella Wang and
  • Samir Dalia
  • + 2 authors+ 0 author

16 March 2024

Eosinophils are a type of granulocyte key to immune system modulation seen in a number of disease processes. Nearly every major organ system can be connected to peripheral eosinophilia through a number of different disease processes, ranging from ben...

  • Feature Paper
  • Review
  • Open Access
17 Citations
22,441 Views
21 Pages

Cold Agglutinin Disease: Improved Understanding of Pathogenesis Helps Define Targets for Therapy

  • Sigbjørn Berentsen,
  • Shirley D’Sa,
  • Ulla Randen,
  • Agnieszka Małecka and
  • Josephine M. I. Vos

20 September 2022

The last 2 decades have seen great progress in understanding the pathogenesis of cold agglutinin disease (CAD) and development of effective therapies. Cold agglutinins can cause hemolytic anemia as well as peripheral circulatory symptoms such as acro...

(This article belongs to the Special Issue Waldenström Macroglobulinaemia and Related Conditions)
  • Review
  • Open Access
4 Citations
20,706 Views
15 Pages

4 August 2025

Background/Objectives: Pica, the compulsive ingestion of non-nutritive substances, has long been observed in patients with iron deficiency anemia (IDA). This behavior is particularly noted in adults, including pregnant women, and poses both diagnosti...

(This article belongs to the Section Non Neoplastic Blood Disorders)
  • Review
  • Open Access
2 Citations
19,921 Views
19 Pages

21 March 2022

Follicular helper T-cell (TFH) lymphomas comprise a unique group of T-cell lymphomas that represent neoplastic proliferations of follicular helper T-cells and share genetic, immunophenotypic, morphologic, and clinical features. Angioimmunoblastic T-c...

(This article belongs to the Special Issue Classification of Lymphomas and Hematological Neoplasia in the Era of Genomic Research: A Themed Issue in Honor of Dr. Elaine S. Jaffe)
  • Review
  • Open Access
6 Citations
18,327 Views
11 Pages

13 February 2022

Cold agglutinin disease (CAD) is a distinct clinicopathologic entity characterized by clonal B-cell lymphoproliferative disorder in the bone marrow. B-cell gene mutations affect NF-ΚB as well as chromatin modification and remodeling pathways. C...

(This article belongs to the Special Issue Classification of Lymphomas and Hematological Neoplasia in the Era of Genomic Research: A Themed Issue in Honor of Dr. Elaine S. Jaffe)
  • Review
  • Open Access
5 Citations
18,001 Views
13 Pages

Bing–Neel Syndrome: Update on Diagnosis and Treatment

  • Evangeline Y. Wong,
  • Shirley D’Sa,
  • Monique C. Minnema,
  • Jorge J. Castillo and
  • Dipti Talaulikar

29 November 2022

Bing–Neel syndrome (BNS) is a rare neurological complication of Waldenström macroglobulinaemia. We highlight key issues in clinical presentation, diagnosis, and treatment while focusing on new and emerging therapies available for patients...

(This article belongs to the Special Issue Waldenström Macroglobulinaemia and Related Conditions)
  • Conference Report
  • Open Access
2 Citations
17,825 Views
30 Pages

Lymphadenitis/Reactive-Hyperplasia, Mimickers of Lymphomas, Low-Grade B-Cell Lymphomas, and Hodgkin Lymphoma

  • A. Nicolae,
  • E. Sabattini,
  • M. Ponzoni,
  • M. Paulli and ,
  • M. Lucioni,
  • T. Salviato and
  • A. Carbone
  • + 2 authors+ 0 author

20 September 2024

A two-day meeting on controversial topics in hematopathology was held in Bologna, Italy, on 19–20 January 2024. The meeting primarily targeted pathologists lacking experience in hematological neoplasms and pathologists in training. The course a...

(This article belongs to the Section Lymphomas)
  • Review
  • Open Access
5 Citations
17,452 Views
19 Pages

Pathophysiology of Myelodysplastic Syndromes

  • Michaela Fontenay,
  • Batoul Farhat and
  • Ismael Boussaid

26 July 2021

Ineffective hematopoiesis is the major characteristic of early myelodysplastic syndromes. Its pathophysiology relies on a diversity of mechanisms supported by genetic events that develop in aging hematopoietic stem cells. Deletion and mutations trigg...

(This article belongs to the Special Issue Challenges in the Treatment of Myelodysplastic Syndrome)
  • Feature Paper
  • Review
  • Open Access
9 Citations
17,183 Views
26 Pages

Polyneuropathy Associated with IgM Monoclonal Gammopathy; Advances in Genetics and Treatment, Focusing on Anti-MAG Antibodies

  • Johannes P. M. van de Mortel,
  • Shirley D’Sa,
  • Alexander F. J. E. Vrancken,
  • Nicolette C. Notermans and ,
  • Josephine M. I. Vos and
  • Monique C. Minnema
  • + 1 author+ 0 author

17 October 2022

With increasing age, the chances of developing either MGUS or polyneuropathy increase as well. In some cases, there is a causative relationship between the IgM M-protein and polyneuropathy. In approximately half of these cases, IgM targets the myelin...

(This article belongs to the Special Issue Waldenström Macroglobulinaemia and Related Conditions)
  • Feature Paper
  • Article
  • Open Access
28 Citations
16,858 Views
20 Pages

Burkitt Lymphoma Incidence in Five Continents

  • Sam M. Mbulaiteye and
  • Susan S. Devesa

13 July 2022

Burkitt lymphoma (BL) is a rare non-Hodgkin lymphoma first described in 1958 by Denis Burkitt in African children. BL occurs as three types, endemic, which occurs in Africa and is causally attributed to Epstein-Barr virus and P. falciparum infections...

(This article belongs to the Special Issue Classification of Lymphomas and Hematological Neoplasia in the Era of Genomic Research: A Themed Issue in Honor of Dr. Elaine S. Jaffe)
  • Review
  • Open Access
1 Citations
16,325 Views
14 Pages

Fasting and Diet: Overview in Chronic Lymphocytic Leukemia

  • Alessandra Trojani,
  • Luca Emanuele Bossi and
  • Roberto Cairoli

19 October 2024

Background: This review aims to provide an overview of the potential impact of fasting and diet on cancer, and in particular, on chronic lymphocytic leukemia (CLL), which is the most frequent form of leukemia in the Western world. Methods: Experiment...

(This article belongs to the Section Leukemias)
  • Review
  • Open Access
11 Citations
15,223 Views
42 Pages

Why Immunotherapy Fails in Multiple Myeloma

  • Luis Gerardo Rodríguez-Lobato,
  • Aina Oliver-Caldés,
  • David F. Moreno,
  • Carlos Fernández de Larrea and
  • Joan Bladé

22 December 2020

Multiple myeloma remains an incurable disease despite great advances in its therapeutic landscape. Increasing evidence supports the belief that immune dysfunction plays an important role in the disease pathogenesis, progression, and drug resistance....

(This article belongs to the Special Issue Immunotherapy in Myeloma: A Theme Issue in Honor of Prof. Dr. Gösta Gahrton)
  • Review
  • Open Access
1 Citations
13,647 Views
31 Pages

TSAT-Urated Insights: Clarifying the Complexities of Hereditary Hemochromatosis and Its Guidelines

  • Chiara Marcon,
  • Marta Medeot,
  • Alessio Michelazzi,
  • Valentina Simeon and ,
  • Alessandra Poz,
  • Sara Cmet,
  • Elisabetta Fontanini,
  • Anna Rosa Cussigh,
  • Marianna Chiozzotto and
  • Giovanni Barillari
  • + 5 authors+ 0 author

11 December 2024

Hereditary hemochromatosis (HH) related to HFE-gene mutations is a well-known condition, yet its understanding remains complex. The BIOIRON classification emphasizes that only homozygosity for the C282Y mutation should be considered pathogenic. The p...

(This article belongs to the Section Non Neoplastic Blood Disorders)
  • Review
  • Open Access
6 Citations
13,528 Views
16 Pages

TP53 Mutant Acute Myeloid Leukemia: The Immune and Metabolic Perspective

  • Federico Zingarelli,
  • Letizia Zannoni and
  • Antonio Curti

15 November 2022

TP53 mutated/deleted acute myeloid leukemia (AML) stands out as one of the poorest prognosis forms of acute leukemia with a median overall survival not reaching one year in most cases, even in selected cases when allogenic stem-cell transplantation i...

(This article belongs to the Special Issue Memorial Issue Dedicated to Prof. Dr. Michele Baccarani: An Excellent Hematologist on Chronic Myeloid Leukemia)
  • Review
  • Open Access
3 Citations
13,329 Views
13 Pages

Parenteral Iron Therapy for Pediatric Patients

  • Elpis Mantadakis,
  • Sonia Alexiadou and
  • Panagiota Zikidou

19 January 2024

Iron deficiency (ID) is by far the most common nutritional disorder in developing and developed countries. When left untreated, ID leads to anemia. Although the usually recommended treatment for iron deficiency anemia (IDA) is oral iron therapy with...

(This article belongs to the Section Non Neoplastic Blood Disorders)
  • Review
  • Open Access
11 Citations
13,308 Views
23 Pages

Primary Cutaneous B-Cell Lymphoma: An Update on Pathologic and Molecular Features

  • Marco Lucioni,
  • Sara Fraticelli,
  • Giuseppe Neri,
  • Monica Feltri and ,
  • Giuseppina Ferrario,
  • Roberta Riboni and
  • Marco Paulli
  • + 2 authors+ 0 author

29 May 2022

Primary cutaneous B-cell lymphomas (PCBCLs) account for 25% of all primary cutaneous lymphomas. Three major types are currently recognized by the WHO classification: primary cutaneous marginal zone B-cell lymphoma (PCMZL), primary cutaneous follicle...

(This article belongs to the Special Issue Classification of Lymphomas and Hematological Neoplasia in the Era of Genomic Research: A Themed Issue in Honor of Dr. Elaine S. Jaffe)
  • Review
  • Open Access
8 Citations
13,184 Views
14 Pages

17 April 2024

The World Health Organization (WHO) “Classification of Tumours of Haematopoietic and Lymphoid Tissues”, published in 2001 and subsequently updated in 2008 and 2017, defined disease entities based on morphologic and phenotypic characterist...

(This article belongs to the Section Lymphomas)
  • Feature Paper
  • Review
  • Open Access
10 Citations
12,684 Views
20 Pages

Molecular Pathogenesis of Follicular Lymphoma: From Genetics to Clinical Practice

  • Cristina López,
  • Pablo Mozas,
  • Armando López-Guillermo and
  • Sílvia Beà

26 September 2022

Follicular lymphoma (FL), a generally indolent disease that derives from germinal center (GC) B cells, represents around 20–25% of all new lymphomas diagnosed in Western countries. The characteristic t(14;18)(q32;q21) translocation that places...

(This article belongs to the Special Issue Classification of Lymphomas and Hematological Neoplasia in the Era of Genomic Research: A Themed Issue in Honor of Dr. Elaine S. Jaffe)
  • Review
  • Open Access
8 Citations
12,651 Views
22 Pages

Future Developments in the Treatment of AL Amyloidosis

  • Foteini Theodorakakou,
  • Despina Fotiou,
  • Meletios A. Dimopoulos and
  • Efstathios Kastritis

7 February 2022

The treatment of AL amyloidosis has evolved, and outcomes have improved, but primarily for patients with low or intermediate-risk disease. Recent advances have been limited to improvements in anti-clonal therapies, which, alone, cannot change the poo...

(This article belongs to the Special Issue Advances in Amyloidosis: A Theme Issue in Honor of Prof. Dr. Giampaolo Merlini)
  • Feature Paper
  • Review
  • Open Access
13 Citations
12,329 Views
18 Pages

Inflammatory and Immune Disorders Associated with Myelodysplastic Syndromes

  • Vincent Jachiet,
  • Pierre Fenaux,
  • Anna Sevoyan,
  • Yervand Hakobyan and ,
  • Lionel Ades,
  • Olivier Fain,
  • Arsène Mekinian and
  • on behalf of the MINHEMON and GFM
  • + 3 authors+ 0 author

24 May 2021

Systemic auto-inflammatory or autoimmune diseases (SIADs) develop in up to a quarter of patients with myelodysplastic syndromes (MDS) or chronic myelomonocytic leukemia (CMML). With or without the occurrence of SIADs, the distribution of MDS subtypes...

(This article belongs to the Special Issue Challenges in the Treatment of Myelodysplastic Syndrome)
  • Review
  • Open Access
7 Citations
12,070 Views
9 Pages

21 July 2022

The definitions of follicular lymphoma (FL) and diffuse large B-cell lymphoma (DLBCL) are evolving in the era of personalized medicine. Early stages of the evolution of FL have been recognized. Two histological manifestations of early lesions are in...

(This article belongs to the Special Issue Classification of Lymphomas and Hematological Neoplasia in the Era of Genomic Research: A Themed Issue in Honor of Dr. Elaine S. Jaffe)
  • Feature Paper
  • Review
  • Open Access
14 Citations
11,848 Views
44 Pages

Neurovascular Manifestations of Sickle Cell Disease

  • Marialuisa Zedde,
  • Micol Quaresima,
  • Isabella Capodanno,
  • Ilaria Grisendi and ,
  • Federica Assenza,
  • Manuela Napoli,
  • Claudio Moratti,
  • Claudio Pavone,
  • Lara Bonacini and
  • Rosario Pascarella
  • + 9 authors+ 4 authors

9 August 2024

Sickle cell disease (SCD) is a hereditary blood disorder characterized by abnormal hemoglobin, leading to the sickle shape of red blood cells. It has several vascular complications and the cerebrovascular ones are among the most frequent and severe b...

(This article belongs to the Section Non Neoplastic Blood Disorders)
  • Review
  • Open Access
22 Citations
11,546 Views
15 Pages

Light Chain Stabilization: A Therapeutic Approach to Ameliorate AL Amyloidosis

  • Gareth J. Morgan,
  • Joel N. Buxbaum and
  • Jeffery W. Kelly

5 October 2021

Non-native immunoglobulin light chain conformations, including aggregates, appear to cause light chain amyloidosis pathology. Despite significant progress in pharmacological eradication of the neoplastic plasma cells that secrete these light chains,...

(This article belongs to the Special Issue Advances in Amyloidosis: A Theme Issue in Honor of Prof. Dr. Giampaolo Merlini)
  • Review
  • Open Access
3 Citations
11,408 Views
24 Pages

Diffuse Large B-Cell Lymphoma: Recognition of Markers for Targeted Therapy

  • Laura Tomas-Roca,
  • Marta Rodriguez,
  • Ruth Alonso-Alonso,
  • Socorro M. Rodriguez-Pinilla and
  • Miguel Angel Piris

14 May 2021

Diffuse large B-cell lymphomas (DLBCL)s, the most common type of Non-Hodgkin’s Lymphoma, constitute a heterogeneous group of disorders including different disease sites, strikingly diverse molecular features and a profound variability in the clinical...

  • Review
  • Open Access
5 Citations
10,926 Views
12 Pages

30 June 2022

The Peroxisome proliferator-activated receptors (PPARs) play vital roles in regulating cellular differentiation, proliferation, and caspase-mediated cell death pathways. They are regarded as promising targets for anti-tumor drug development, particul...

  • Article
  • Open Access
2 Citations
10,372 Views
18 Pages

Real-World Outcomes of Anti-CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy for Third-Line Relapsed or Refractory Diffuse Large B-Cell Lymphoma: A Single-Center Study

  • Aishwarya Sridhar,
  • Thomas S. Gunning,
  • Alexandra Della Pia,
  • Xiaopei Zhang and ,
  • Jaeil Ahn,
  • Brittany Sinclaire,
  • Brittany Lukasik,
  • Christina Cho,
  • Michele L. Donato and
  • Andrew Ip
  • + 10 authors+ 5 authors

28 January 2025

Background: Diffuse large B-cell lymphoma (DLBCL) is the most common diagnosed aggressive B-cell lymphoma, with poor outcomes in those who experience relapsed or refractory (R/R) disease. Landmark clinical trials have demonstrated the efficacy and sa...

(This article belongs to the Section Lymphomas)
  • Review
  • Open Access
7 Citations
10,245 Views
11 Pages

21 January 2022

Light chain amyloidosis is a complex disease where a small B-cell clone produces a monoclonal immunoglobulin light chain that causes deposits and specific organ dysfunction. The available treatment strategies aim to reduce or eliminate amyloidogenic...

(This article belongs to the Special Issue Advances in Amyloidosis: A Theme Issue in Honor of Prof. Dr. Giampaolo Merlini)
  • Review
  • Open Access
1 Citations
9,966 Views
10 Pages

2 July 2024

Monoclonal antibody (MoAb) therapy has been increasingly used in recent years for hematologic malignancies. The MoAbs anti-CD38 and anti-CD47 are immunoglobulins directed against epitopes that are highly expressed not only on cancer cells, but also o...

  • Review
  • Open Access
12 Citations
9,426 Views
16 Pages

12 January 2022

The deposition of amyloid light chains (LCs) in target sites translates into tissue damage and organ dysfunction. Clinical and experimental advances have cast new light on the pathophysiology of damage in AL amyloidosis. The currently accepted view i...

(This article belongs to the Special Issue Advances in Amyloidosis: A Theme Issue in Honor of Prof. Dr. Giampaolo Merlini)
  • Review
  • Open Access
5 Citations
9,408 Views
57 Pages

22 April 2025

Clonal hematopoiesis (CH) is an age-related process in which hematopoietic stem/progenitor cells increase their fitness due to the acquisition of mutations that lead to a proliferative advantage and to clonal expansion. Its frequency increases with a...

(This article belongs to the Section Leukemias)
  • Review
  • Open Access
5 Citations
9,399 Views
11 Pages

25 August 2021

Myelodysplastic syndromes are clonal disorders with morphological dysplasia, a variable degree of cytopenia and a risk of transformation to acute myeloid leukemia. Prognosis is very variable and is defined by blast count, cytopenia, cytogenetics and...

(This article belongs to the Special Issue Challenges in the Treatment of Myelodysplastic Syndrome)
  • Feature Paper
  • Review
  • Open Access
2 Citations
9,346 Views
13 Pages

Transformed Waldenström Macroglobulinemia: Update on Diagnosis, Prognosis and Treatment

  • Eric Durot,
  • Cécile Tomowiak,
  • Elise Toussaint,
  • Pierre Morel and ,
  • Dipti Talaulikar,
  • Prashant Kapoor,
  • Jorge J. Castillo and
  • Alain Delmer
  • + 3 authors+ 0 author

12 October 2022

Histological transformation (HT) to an aggressive lymphoma results from a rare evolution of Waldenström macroglobulinemia (WM). A higher incidence of transformation events has been reported in MYD88 wild-type WM patients. HT in WM can be histolo...

(This article belongs to the Special Issue Waldenström Macroglobulinaemia and Related Conditions)
  • Article
  • Open Access
1 Citations
9,229 Views
11 Pages

IgM-Related Immunoglobulin Light Chain (AL) Amyloidosis

  • Shayna Sarosiek,
  • Andrew R. Branagan,
  • Steven P. Treon and
  • Jorge J. Castillo

15 November 2022

Waldenström macroglobulinemia (WM) is a rare lymphoplasmacytic disorder characterized by an IgM paraprotein. The clinical presentation of WM varies and can include common manifestations such as anemia and hyperviscosity, in addition to less comm...

(This article belongs to the Special Issue Waldenström Macroglobulinaemia and Related Conditions)
  • Case Report
  • Open Access
9,213 Views
8 Pages

Refractory/Relapsed Classic Hodgkin Lymphoma Mimicking Disseminated Tuberculosis

  • Mohamed Nazem Alibrahim,
  • Hussein Hammam,
  • Antonino Carbone,
  • Noor Alsaleh and
  • Annunziata Gloghini

Background/Objectives: Classic Hodgkin lymphoma (cHL) is a predominantly curable B-cell malignancy. However, primary refractory and relapsed (R/R) cHL remain therapeutic challenges, especially in regions with high tuberculosis (TB) prevalence, where...

(This article belongs to the Section Lymphomas)
  • Review
  • Open Access
4 Citations
8,913 Views
12 Pages

New Targets for PET Imaging of Myeloma

  • Mona-Elisabeth Revheim,
  • Caroline Stokke,
  • Jakob Nordberg Nørgaard,
  • Hilde Feiring Phillips and ,
  • Alexander Gul Sherwani,
  • Fredrik Schjesvold and
  • James P. Connelly
  • + 2 authors+ 0 author

2 December 2021

Recent advances in the treatment of multiple myeloma (MM) have increased the need for accurate diagnosis and detection of minimal residual disease (MRD), disease characterization and localization, and response evaluation and prognostication. Positron...

(This article belongs to the Special Issue Current and Upcoming Diagnostics and Prognostics in Multiple Myeloma)
  • Review
  • Open Access
4 Citations
8,814 Views
10 Pages

IgM-Associated Cryoglobulinaemia

  • Jahanzaib Khwaja,
  • Simon J. Salter and
  • Shirley D’Sa

21 July 2023

Cryoglobulinaemia is characterised by serum immunoglobulins that precipitate at temperatures below 37 °C and redissolve on warming. Monoclonal IgM immunoglobulin can be associated with type I and II cryoglobulinaemia with underlying Waldenstr&oum...

(This article belongs to the Section Plasma Cell Disorders)
  • Review
  • Open Access
2 Citations
8,711 Views
11 Pages

Mediastinal Gray-Zone Lymphoma: Still an Open Issue

  • Stefano Pileri,
  • Valentina Tabanelli,
  • Roberto Chiarle,
  • Angelica Calleri and ,
  • Federica Melle,
  • Giovanna Motta,
  • Maria Rosaria Sapienza,
  • Elena Sabattini,
  • Pier Luigi Zinzani and
  • Enrico Derenzini
  • + 5 authors+ 0 author

27 June 2023

The concept of gray-zone lymphoma (GZL) has been progressively refined since its introduction in the literature in 1998. For several years, it was applied to a rather broad spectrum of conditions, posing the problem of the differential diagnosis betw...

(This article belongs to the Section Lymphomas)
  • Feature Paper
  • Review
  • Open Access
4 Citations
8,659 Views
13 Pages

10 March 2022

Indolent T- and NK-cell lymphoproliferative disorders of the gastrointestinal tract are uncommon clonal neoplasms that have a protracted clinical course and limited response to therapy. In recent years, advances in the immunophenotypic, genetic, and...

(This article belongs to the Special Issue Classification of Lymphomas and Hematological Neoplasia in the Era of Genomic Research: A Themed Issue in Honor of Dr. Elaine S. Jaffe)
  • Review
  • Open Access
3 Citations
8,594 Views
26 Pages

Chronic Myelomonocytic Leukemia Gold Jubilee

  • Eric Solary and
  • Raphael Itzykson

1 July 2021

Chronic myelomonocytic leukemia (CMML) was named 50 years ago to describe a myeloid malignancy whose onset is typically insidious. This disease is now classified by the World Health Organisation as a myelodysplastic syndrome (MDS)-myeloproliferative...

(This article belongs to the Special Issue Challenges in the Treatment of Myelodysplastic Syndrome)
  • Brief Report
  • Open Access
8,410 Views
6 Pages

Selective IgA Deficiency and Blood Component Transfusion: In Search of the Lost Evidence

  • Pilar Solves,
  • Ana Bataller,
  • Ana Belén Gálvez,
  • Pedro Asensi Cantó and ,
  • Marta Santiago,
  • María José Moreno,
  • Inés Gómez-Seguí and
  • Javier de la Rubia
  • + 3 authors+ 0 author

26 March 2024

Background: Selective IgA deficiency (IgA-D) has been historically considered a high-risk entity for developing allergic/anaphylactic reactions after blood transfusion (AATRs). However, it has been suggested that the IgA-D-related anaphylactic transf...

  • Review
  • Open Access
6 Citations
8,357 Views
21 Pages

2 January 2021

Impaired hematopoiesis is a serious complication after allogeneic hematopoietic stem cell transplantation (allo-HSCT). Bone marrow aplasia and peripheral cytopenias arise from primary and secondary graft failure or primary and secondary poor graft fu...

(This article belongs to the Section Plasma Cell Disorders)
  • Perspective
  • Open Access
4 Citations
8,181 Views
16 Pages

4 January 2023

New insights from genomic studies have had an impact on the definition and the diagnosis of several lymphoid tumors including follicular B-cell lymphomas, aggressive diffuse large B-cell lymphomas, and lymphoproliferations associated with acquired an...

(This article belongs to the Section Lymphomas)
  • Review
  • Open Access
6 Citations
8,135 Views
23 Pages

13 April 2023

Waldenström macroglobulinemia (WM) is a rare, non-Hodgkin lymphoma that remains incurable. Rituximab, an anti-CD20 monoclonal antibody has been the cornerstone of treatment against WM, and its combination with an alkylator, bendamustine, achieve...

(This article belongs to the Special Issue Waldenström Macroglobulinaemia and Related Conditions)
  • Editorial
  • Open Access
3 Citations
7,985 Views
16 Pages

4 July 2025

In recent decades, significant progress in medicine has improved the outcomes for Hodgkin lymphoma (HL), a malignancy affecting approximately 8570 new patients annually in the United States and causing around 910 deaths per year [...]

  • Feature Paper
  • Review
  • Open Access
2 Citations
7,934 Views
12 Pages

14 June 2023

Renal disorders are uncommonly associated with IgM MGUS and Waldenström macroglobulinaemia (WM). Data are limited to large case series that suggest that related renal involvement occurs in 5% of patients with WM. Although uncommon, there is a mu...

(This article belongs to the Special Issue Waldenström Macroglobulinaemia and Related Conditions)
  • Review
  • Open Access
5 Citations
7,842 Views
19 Pages

Genetics of Transformed Follicular Lymphoma

  • Miguel Alcoceba,
  • María García-Álvarez,
  • Jessica Okosun,
  • Simone Ferrero and ,
  • Marco Ladetto,
  • Jude Fitzgibbon and
  • Ramón García-Sanz
  • + 2 authors+ 0 author

1 October 2022

Histological transformation (HT) to a more aggressive disease–mostly diffuse large B-cell lymphoma–is considered one of the most dismal events in the clinical course of follicular lymphoma (FL). Current knowledge has not found a single bi...

(This article belongs to the Special Issue Classification of Lymphomas and Hematological Neoplasia in the Era of Genomic Research: A Themed Issue in Honor of Dr. Elaine S. Jaffe)
  • Systematic Review
  • Open Access
8 Citations
7,676 Views
19 Pages

1 November 2023

Monoclonal gammopathy of undetermined significance (MGUS) is a pre-malignant plasma cell disorder with an etiology that is incompletely understood. Modifiable risk factors and genetic predispositions likely interact to increase MGUS risk in specific...

(This article belongs to the Section Plasma Cell Disorders)
XFacebookLinkedIn
Hemato - ISSN 2673-6357